Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Sterol lactam compound puffball lactam and use thereof in preparation of anticomplement drugs

A technology of sterol lactam and puffball lactam, which is applied in the field of new sterol lactam compound puffball lactam and the preparation of anti-complement drugs, and can solve the problems of unreported structure and biological activity.

Active Publication Date: 2016-10-05
FUDAN UNIV
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The invention of the present application intends to provide a new compound of sterol lactam isolated from puffball, named as puffball lactam. see the report

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sterol lactam compound puffball lactam and use thereof in preparation of anticomplement drugs
  • Sterol lactam compound puffball lactam and use thereof in preparation of anticomplement drugs
  • Sterol lactam compound puffball lactam and use thereof in preparation of anticomplement drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Embodiment 1 prepares puff lactam

[0015] Take 25kg of the fruiting body of the medicinal material puffball, pulverize it, and reflux extract it with 95% ethanol for 3 times (50L×3), each time for 2h, combine the extracts and concentrate to obtain 0.85kg of extract, add water (4L) to suspend, respectively The volume of petroleum ether, ethyl acetate and n-butanol was extracted 5 times, and the extracts were combined and concentrated to dryness to obtain 160 g of ethyl acetate extract; the ethyl acetate extraction part was separated by silica gel (200-300 mesh) column chromatography, followed by Gradient elution with dichloromethane-methanol (50:1-0:1) gave 10 fractions (Fr.1-10), of which fraction Fr.6 (14g) was subjected to silica gel column chromatography (dichloromethane- methanol, 30:1,20:1,10:1,5:1,3:1), Sephadex LH-20 column chromatography (chloroform-methanol, 1:1) and HPLC (methanol-water, 20:80-80 :20, gradient elution) and other means to purify, separate and...

Embodiment 2

[0017] Example 2 Anti-complement classical pathway test in vitro

[0018] Take 0.04ml of complement (guinea pig serum), add barbiturate buffer solution (BBS) to prepare a 1:10 solution, and double-dilute with BBS to 1:20, 1:40, 1:80, 1:160, 1:10 320, 1:640 and 1:1280 solutions; take 0.1ml of 1:1000 hemolysin, 2% sheep red blood cell (SRBC) and 0.2ml of complement of each concentration, dissolve in 0.2ml BBS, mix well, and bathe in 37℃ water for 30min Put it into a low-temperature high-speed centrifuge, and centrifuge at 4000rpm and 4°C for 5min. Take 0.2ml of the supernatant from each tube in a 96-well plate, and measure its absorbance at 405nm; at the same time, a complete hemolysis group (0.1ml 2% SRBC, 0.1ml hemolysin dissolved in 0.4ml triple-distilled water) was set up to lyse the blood vessels with triple-distilled water. The absorbance was used as the whole hemolysis standard to calculate the hemolysis rate. Take the complement dilution as the X-axis and the hemolysis...

Embodiment 3

[0019] Example 3 Anti-complement alternative pathway test in vitro

[0020] Take 0.2ml of complement (human serum), add AP diluent (barbital buffer, pH=7.4, containing 5mMMg 2+,8mM EGTA) was prepared as a 1:5 solution, and diluted into 1:10, 1:20, 1:40, 1:80, 1:160, 1:320 and 1:640 solutions; take each concentration Complement 0.15ml, AP diluent 0.15ml and 0.5% rabbit erythrocyte (RE) 0.20ml, mix well, put in a low-temperature high-speed centrifuge after 30min in 37℃ water bath, centrifuge at 4000rpm, 4℃ for 5min. Take 0.2ml of the supernatant from each tube in a 96-well plate, and measure the absorbance at 405nm; at the same time, a complete hemolysis group (0.20ml 0.5% RE dissolved in 0.3ml triple-distilled water) was set up in the experiment, and the absorbance of triple-distilled water-lyzed blood vessel was used as the standard of total hemolysis , calculate the hemolysis rate, draw the graph with the complement dilution as the X-axis and the hemolysis percentage as the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of traditional Chinese medicine pharmacy and relates to a sterol lactam compound and use thereof in preparation of anticomplement drugs. According to the sterol lactam compound and the use thereof, the sterol lactam compound, i.e., puffball lactam is obtained through being separated from fruiting bodies of puffballs, and the compound is ergosterol of B-ring lactam; and proven by anticomplementary activity evaluation tests, the sterol lactam compound, i.e., puffball lactam has a relatively high inhibiting effect on activation of a classical pathway and alternative pathway of a complement system, has the CH50 value of 0.032+ / -0.007mg / ml and has the AP50 value of 0.067+ / -0.009mg / ml. The compound can be used for preparing complement inhibitors.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine pharmacy, and relates to a new sterol lactam compound piprolactam and its application in preparing anti-complement drugs. Background technique [0002] It is disclosed in the prior art that excessive activation of the complement system can cause many major diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and acute respiratory distress syndrome (ARDS). The study of anti-complement drugs has been the focus and focus of the world's pharmaceutical research for many years. However, there is still a lack of ideal therapeutic drugs for such diseases at present, so there is an urgent need for high-efficiency, low-toxicity, and specific new complement inhibitors in clinical practice. The research and development of complement inhibitors from natural products is an important research field that has received more and more attention in recent years, and it has the ch...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07J73/00A61P37/02A61P19/02A61P29/00A61P11/00
Inventor 陈道峰范明松黄成钢
Owner FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com